Expanded Access for LJPC-501
NCT03245528
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Catecholamine Resistant Hypotension (CRH)
Distributive Shock
High Output Shock
Sepsis
Vasodilatory Shock
Interventions
DRUG:
LJPC-501
Sponsor
La Jolla Pharmaceutical Company